Literature DB >> 11994707

Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps.

Joaquim Mullol1, Joan C Fernàndez-Morata, Jordi Roca-Ferrer, Laura Pujols, Antoni Xaubet, Pedro Benitez, Cesar Picado.   

Abstract

BACKGROUND: There is evidence that impairment of prostanoid metabolism might be involved in the pathogenesis of nasal polyps (NPs). Prostanoids are synthesized by 2 cyclooxygenase (Cox) enzymes, one constitutive (Cox-1) and another inducible (Cox-2).
OBJECTIVE: The aim of these studies was to investigate Cox-1 and Cox-2 regulation in NPs of aspirin-tolerant human patients compared with that seen in nasal mucosa (NM).
METHODS: Cultured explants from human NPs and healthy mucosa from patients undergoing polypectomy and corrective nasal surgery, respectively, were examined for Cox-1 and Cox-2 expression by means of semiquantitative competitive PCR and Western blotting.
RESULTS: Cox-1 mRNA was spontaneously upregulated in cultured NM but not in NPs. A spontaneous but delayed upregulation of Cox-2 mRNA was found in NPs (24 hours) compared with that seen in NM (6 hours). After cytokine stimulation (IFN-gamma, IL-1beta, and TNF-alpha), the induction of Cox-2 mRNA and protein was also faster in NM (1 hour) than in NPs (4 hours).
CONCLUSION: These data showing an abnormal regulation of Cox-1 and Cox-2 in NPs from aspirin-tolerant patients reinforce the concept that prostanoid metabolism might be important in the pathogenesis of inflammatory nasal diseases and suggest a potential role for this alteration in the formation of NPs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994707     DOI: 10.1067/mai.2002.123534

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

1.  Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)?

Authors:  Ludger Klimek; Ralph Dollner; Oliver Pfaar; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

Review 2.  Pathogenesis of aspirin-exacerbated respiratory disease.

Authors:  Donald D Stevenson; Bruce L Zuraw
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

3.  Association of the -14C/G MET and the -765G/C COX-2 gene polymorphisms with the risk of chronic rhinosinusitis with nasal polyps in a Polish population.

Authors:  Przemyslaw Sitarek; Hanna Zielinska-Blizniewska; Lukasz Dziki; Jaroslaw Milonski; Karolina Przybylowska; Bartosz Mucha; Jurek Olszewski; Ireneusz Majsterek
Journal:  DNA Cell Biol       Date:  2012-03-14       Impact factor: 3.311

Review 4.  Gene expression signatures: a new approach to understanding the pathophysiology of chronic rhinosinusitis.

Authors:  Chunwei Li; Li Shi; Yan Yan; Bruce R Gordon; William M Gordon; De-Yun Wang
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

5.  Aspirin-exacerbated asthma.

Authors:  Mathew Varghese; Richard F Lockey
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

6.  Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis.

Authors:  J Roca-Ferrer; L Pujols; S Gartner; A Moreno; F Pumarola; J Mullol; N Cobos; C Picado
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

7.  Reconstituted human upper airway epithelium as 3-d in vitro model for nasal polyposis.

Authors:  Francisco de Borja Callejas; Asunción Martínez-Antón; Isam Alobid; Mireya Fuentes; Julio Cortijo; César Picado; Jordi Roca-Ferrer; Joaquim Mullol
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

8.  Involvement of B2 receptor in bradykinin-induced proliferation and proinflammatory effects in human nasal mucosa-derived fibroblasts isolated from chronic rhinosinusitis patients.

Authors:  Yih-Jeng Tsai; Sheng-Po Hao; Chih-Li Chen; Brian J Lin; Wen-Bin Wu
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

Review 9.  Cyclooxygenases and the pathogenesis of chronic rhinosinusitis and nasal polyposis.

Authors:  Josep M Guilemany; Jordi Roca-Ferrer; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2008-05       Impact factor: 4.919

10.  An intranasal selective antisense oligonucleotide impairs lung cyclooxygenase-2 production and improves inflammation, but worsens airway function, in house dust mite sensitive mice.

Authors:  Rosa Torres; Aida Herrerias; Mariona Serra-Pagès; Jordi Roca-Ferrer; Laura Pujols; Alberto Marco; César Picado; Fernando de Mora
Journal:  Respir Res       Date:  2008-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.